RELATIONSHIP OF VENOM EFFECTS TO VENOM ANTIGEN AND ANTIVENOM SERUM CONCENTRATIONS IN A PATIENT WITH CROTALUS-ATROX ENVENOMATION TREATED WITH A FAB ANTIVENOM
Sa. Seifert et al., RELATIONSHIP OF VENOM EFFECTS TO VENOM ANTIGEN AND ANTIVENOM SERUM CONCENTRATIONS IN A PATIENT WITH CROTALUS-ATROX ENVENOMATION TREATED WITH A FAB ANTIVENOM, Annals of emergency medicine, 30(1), 1997, pp. 49-53
Study objective: To described the association among venom antigenemia,
serum antivenom concentrations, and Venom effects in a 53-year-old wo
man who was bitten by a Western diamondback rattlesnake (Crotalus atro
x). Methods: The patient was enrolled in a multicenter trial of an inv
estigational Fab antivenom. Her clinical condition and coagulation par
ameters were monitored for 2 weeks after the bite. Results: After anti
venom administration, the progression of the venom's effects was arres
ted. The antivenom reversed some local venom effects, caused venom ant
igens to disappear from the blood, and resolved the patient's profound
thrombocytopenia (before antivenom, 12,000/mm(3); 1 hour after antive
nom, 227,000/mm(3)). Local venom effects recurred twice in the 24 hour
s after antivenom administration but were easily managed with addition
al Fab antivenom. Venom antigenemia was detected on days 5 and 8 after
the initial treatment and was accompanied in one instance by the new
onset of hypofibrinogenemia (119 mg/L) that resolved spontaneously and
in both instances by renewed profound thrombocytopenia. Repeat Fab an
tivenom doses on days 6 and 9 were followed by increases in platelet c
ount (from 16,000 to 40,000/mm(3) and from 11,000 to 20,000/mm(3), res
pectively) and by the reduction or disappearance of venom antigenemia.
The patient sustained no significant bleeding complications, and all
laboratory values had returned to normal 2 weeks after the bite. Concl
usion: initial control of local symptoms and coagulopathy was prompt a
fter the administration of Fab antivenom. Repeat doses during the 24 t
o 36 hours after a bite may be necessary for local control. Recrudesce
nce of coagulopathy was likely due in part to renewed venom antigenemi
a after clearance of Fab antivenom. The role of Fab antivenom in the t
reatment of recurrent coagulopathy requires further study.